Home
News
Create
Screeners
Insights
Trualt Bioenergy
428.
30
-2.40
(-0.56%)
Market Cap
₹3,672.78 Cr
PE Ratio
25.05
Industry
FMCG
Buy
Sell
Company Performance:
1D
-0.56%
1M
+3.39%
6M
-19.33%
1Y
-19.33%
5Y
-19.33%
View Company Insights
Latest news about Trualt Bioenergy
TruAlt Bioenergy Reports Strategic Revenue Decline, Eyes Strong Recovery with Multi-Feed Operations
Nov 19, 2025
TruAlt Bioenergy Limited reported a 26% year-on-year revenue decline to INR 418.00 crores in H1 FY26 due to plant shutdowns for capacity conversion. Despite this, EBITDA margins improved through cost control measures. The company produced 5.70 crore liters of ethanol and targets 47.00 crore liters for the current year. TruAlt's Compressed Biogas business grew 65% year-on-year. The company is expanding through partnerships with Sumitomo Corporation and GAIL, developing a retail fuel network, and planning an ethanol-to-SAF plant investment of up to INR 2,250.00 crores. Management expects improved performance in H2 FY26 with potential ethanol production of 31-32 crore liters.
TruAlt Bioenergy Reports Q2 Loss Amid Transition to Year-Round Operations
Nov 12, 2025
Trualt Bioenergy Forges Strategic Partnership with Sumitomo Corp for CBG Plant Development
Nov 11, 2025
Trualt Bioenergy Approves Rs 180 Crore Corporate Guarantee and Rs 20 Crore Investment in Subsidiary
Oct 28, 2025
Trualt Bioenergy Approves Q1 Results and ₹84.21 Crore Stake Acquisition in Trualt Gas
Oct 22, 2025
More news about Trualt Bioenergy
19
Oct 25
Trualt Bioenergy Approves Q1 FY2026 Results and Strategic Acquisition in Compressed Biogas Sector
Trualt Bioenergy Limited's Board has approved the acquisition of a 51% stake in Trualt Gas Private Limited (TGPL) for Rs. 8.42 crore. TGPL, incorporated in 2024, will focus on compressed biogas production from municipal waste and press mud. The acquisition aligns with Trualt's strategy to expand in renewable energy and supports a proposed joint venture with SUMITOMO Corporation. The Board also approved Q1 FY2026 financial results. The deal is expected to complete by November 30, 2025.
06
Oct 25
TruAlt Bioenergy Shares Slip 6.7% Post-Listing Amid Valuation Concerns
TruAlt Bioenergy's stock price has fallen 6.70% from its listing price of Rs 550.00 to Rs 513.10 within two trading sessions after its IPO. The decline comes despite strong financial results, with revenue up 54% to Rs 1,969.00 crore and net profit increasing nearly five-fold to Rs 147.00 crore. Analysts cite concerns over aggressive valuation compared to industry peers, with the company trading at 29 times earnings. Market sentiment remains mixed, with some recommending partial profit booking while others highlight the company's diversified portfolio in India's renewable energy sector.
Trualt Bioenergy
428.
30
-
2.
40
(-
0.
56
%)
1 Year Returns:
-19.33%
Industry Peers
LT Foods
405.15
(-
0.
84
%)
KRBL
390.30
(-
2.
01
%)
Gujarat Ambuja Exports
115.83
(-
3.
02
%)
Kaveri Seed Company
978.20
(+
0.
96
%)
Trualt Bioenergy
428.30
(-
0.
56
%)
GRM Overseas
471.60
(+
0.
54
%)
Sanstar
89.04
(-
1.
25
%)
Chaman Lal Setia Exports
266.40
(-
0.
22
%)
Bombay Super Hybrid Seeds
102.44
(-
2.
06
%)
Avt Natural Products
66.80
(-
0.
19
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation